Ge Vernova Inc. (GEV) Stock — Forensic Analysis, Red Flags & Rating | Stockonomy · Stockonomy
Forensic Analysis · Industrials / Manufacturing / Defense · as of Sep 24, 2026
Ge Vernova Inc. (GEV)
A forensic read on Ge Vernova Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
C · Mixed — selective
Forensic grade
Safe
Financial health
5.6
Distress distance
Clean
Earnings quality
4
Forensic signals
26.3
P / E (ttm)
43.7%
ROE
$253.5B
Market cap
0.16%
Dividend yield
9.0%
Revenue growth
This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence, going concern, valuation). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.
Ge Vernova Inc. earns a C (Mixed — selective) forensic quality grade, and its balance-sheet distress test reads 5.6, placing it in the Safe zone. 4 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
5.7%
FY2025
Return on invested capital.Return on invested capital is 5.7% in the latest fiscal year, against 2% in FY2024. The capital base behind it cannot be compared across FY2024–FY2025: long-term debt is tagged in one of those two fiscal years and not the other, and an untagged line enters this calculation as zero, so any change in the base would be a change in what the filer tagged.
+16.9%
FY2024→FY2025
Accruals ratio (% of NOA).Net operating assets grew +16.9% relative to their own average in FY2025 — scaled by NOA itself, not by total assets, which is what the Forensic Screens card's own accrual row divides by. Accruals are building faster than is comfortable — part of profit is sitting in the balance sheet rather than turning to cash. The build is led by inventory up +21% against +6% in cost of sales and receivables up +20% against revenue +9%. A cash-flow measure on the same base disagrees: reported earnings ran in line with operating cash by 1% of net operating assets, against an accruals ratio of 16.9%. The two are computed differently: the accruals ratio is the change in net operating assets over average net operating assets, while the cash-flow figure is net income less operating cash flow over that same average. Read them as two results, not one.
125d
FY2024→FY2025
Inventory days.Days inventory outstanding moved from 109 to 125 FY2024→FY2025 (against cost of goods sold; inventory +21% vs +6% in cost of sales). Inventory is building a little faster than sales — watch for markdowns. There's no FY2023 figure on file for inventory, so FY2024 has no opening balance to average against — both figures are measured on period-end balances rather than the beginning-plus-ending average, since averaging only the current year would make the move track balance-sheet growth rather than the business.
97% of FCF
Key fundamentals
Latest Revenue$38.07B
Revenue Growth YoY+9.0%
Net Margin12.8%
Free Cash Flow$3.71B
Return on Equity43.7%
Debt / Equity0.03x
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Ge Vernova Inc.'s actual 10-K/10-Q/8-K filings?
Data from SEC EDGAR public filings · metrics as of Sep 24, 2026. Forensic signals flag probability, not certainty.
FY2025
Shareholder returns.Returned $3.6B to shareholders (buybacks + dividends) in FY2025 — 97% of free cash flow. Right at the limit of what free cash flow covers — little room before it's funded by debt or the balance sheet. That ratio has been CLIMBING toward the limit — 3% of free cash flow the year before — not just sitting there. Counting the $257M of stock-based comp paid out in shares on top of that, the combined claim on free cash flow is 104%.